Loading…
Recipharm will invest EUR 15 million for a 51% stake in a new joint venture, Resyca BV, with Medspray, which will contribute its softmist spray nozzle intellectual property for pharmaceutical applications. The venture will develop and exploit the technology.
Recipharm announced on 4 February 2020 that its offer to acquire Consort Medical plc had become unconditional, bringing Consort's 2,000 employees and 10 facilities across the UK, Italy and Germany into the Recipharm Group.